share_log

JMP Securities Maintains Market Outperform on Cue Biopharma, Lowers Price Target to $2

Benzinga ·  Jul 26 14:12  · Ratings

JMP Securities analyst Reni Benjamin maintains Cue Biopharma (NASDAQ:CUE) with a Market Outperform and lowers the price target from $15 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment